Attackers accessed email accounts containing Social Security numbers, medical treatment information, and more.
𝙏𝙝𝙚 𝙂𝙧𝙖𝙙𝙪𝙖𝙩𝙚 𝘾𝙚𝙣𝙩𝙚𝙧 𝙤𝙛 𝙏𝙝𝙚 𝘾𝙞𝙩𝙮 𝙐𝙣𝙞𝙫𝙚𝙧𝙨𝙞𝙩𝙮 𝙤𝙛 𝙉𝙚𝙬 𝙔𝙤𝙧𝙠:
The Neuro-Network.
𝙎𝙘𝙞𝙚𝙣𝙩𝙞𝙨𝙩𝙨 𝙄𝙙𝙚𝙣𝙩𝙞𝙛𝙮 𝙂𝙪𝙩-𝘿𝙚𝙧𝙞𝙫𝙚𝙙 𝙈𝙚𝙩𝙖𝙗𝙤𝙡𝙞𝙩𝙚𝙨 𝙩𝙝𝙖𝙩 𝙋𝙡𝙖𝙮 𝙖 𝙍𝙤𝙡𝙚 𝙞𝙣 𝙉𝙚𝙪𝙧𝙤𝙙𝙚𝙜𝙚𝙣𝙚𝙧𝙖𝙩𝙞𝙤𝙣
Get Surfshark VPN at https://Surfshark.deals/thoughty2 and enter promo code THOUGHTY2 for 83% off and 4 extra months for free!
Get my new book Bread and Circuses: https://bit.ly/breadandcircusesbook.
Continue reading “This Deadly Virus Has Been Frozen for 4 Million Years” »
https://www.youtube.com/watch?v=_KCirsRKFX8&feature=youtu.be
When we think about gene editing, the first thing we remember is the designer babies, and that it’s usually called unethical. But actually, gene editing (CRISPR) may be one of the most promising upcoming medical technologies. Learn why in this video.
Check out other videos from this series:
https://www.youtube.com/playlist?list=PLnWSi4zEceYXPCBYXZ9ZEV-9q44ebksoo.
Continue reading “Gene Editing, The Possible Key To Immortality” »
Europe will soon produce a strategically vital component in the modern global economy as US semiconductor giant Intel chooses the site for a new cutting-edge chip factory.
Recent problems in global supply chains have highlighted the fundamental importance of semiconductors, which are used in a growing number of products including cars, TVs and smartphones.
Keen demand and the closure of semiconductor plants, particularly in Asia, due to pandemic disruptions led to a global chip shortage and forced car manufacturers such as Ford, Nissan and Volkswagen to scale back production.
All 18 COVID-19 patients hospitalized with moderate or severe symptoms who were administered the drug Amor-18 developed by Israeli biotech company Amorphical in a phase II clinical trial recovered and were discharged in a few days, the company announced Wednesday. Of the 19 individuals who were given a placebo, six had to be transferred to intensive care, and two died.
All 18 hospitalized individuals administered the treatment developed by Israeli biotech company Amorphical in a phase II trial recovered and were discharged in a few days.
When three is not enough.
Israel has announced a fourth dose of the COVID-19 vaccine to people older than 16. The additional dose will be given to senior citizens, medical workers, people with suppressed immune system.
Companies and labs are racing to build next-generation devices that track and translate brain activity to help people immobilized by disease or injury handle tasks requiring movement.
Artificial intelligence (AI) backed drug discovery company Insilico Medicine announced last week that it was dosing the first healthy volunteer in a microdose trial of ISM 001–005. Designed with the help of AI, the drug is a small-molecule inhibitor of a biological target that was discovered by Pharma. AI. The trial is being conducted in Australia.
The AI-designed drug will be used to treat chronic lung disease idiopathic pulmonary fibrosis, or IPF usually leads to progressive and irreversible lung-function decline and affects 20 people out of over 100,000 globally.
Chief Scientific Officer of Insilico, Freng Ren, said in a press release that this drug discovery and trial marks a significant milestone in the AI-drug discovery space. This is because the said candidate is the first-ever AI-discovered novel molecule based on an AI-discovered target.
Targeting cancers and viruses, better knowledge of the human immune system is leading to new medicines.
